The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
An oral JAK1 inhibitor is a type of medication that belongs to a class of drugs called Janus kinase (JAK) inhibitors. JAK inhibitors work by targeting and inhibiting the activity of Janus kinases, which are enzymes involved in the signaling pathways of various cytokines and growth factors.
Global Oral JAK1 Inhibitor market is projected to reach US$ 13590 million in 2029, increasing from US$ 8157 million in 2022, with the CAGR of 7.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Oral JAK1 Inhibitor market research.
Key companies engaged in the Oral JAK1 Inhibitor industry include AbbVie, Pfizer, Incyte, Eli Lilly and Bristol-Myers Squibb, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Oral JAK1 Inhibitor were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Oral JAK1 Inhibitor market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Oral JAK1 Inhibitor market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
- AbbVie
- Pfizer
- Incyte
- Eli Lilly
- Bristol-Myers Squibb
Segment by Type
- Brands
- Biosimilar
Segment by Application
- Hospita
- Retail Pharmacy
- Other
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia, Nordic Countries, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea,Southeast Asia, India, Australia, Rest of Asia)
- Latin America (Mexico, Brazil, Rest of Latin America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
The Oral JAK1 Inhibitor report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oral JAK1 Inhibitor Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Brands
1.2.3 Biosimilar
1.3 Market by Application
1.3.1 Global Oral JAK1 Inhibitor Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospita
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oral JAK1 Inhibitor Market Perspective (2018-2029)
2.2 Oral JAK1 Inhibitor Growth Trends by Region
2.2.1 Global Oral JAK1 Inhibitor Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Oral JAK1 Inhibitor Historic Market Size by Region (2018-2023)
2.2.3 Oral JAK1 Inhibitor Forecasted Market Size by Region (2024-2029)
2.3 Oral JAK1 Inhibitor Market Dynamics
2.3.1 Oral JAK1 Inhibitor Industry Trends
2.3.2 Oral JAK1 Inhibitor Market Drivers
2.3.3 Oral JAK1 Inhibitor Market Challenges
2.3.4 Oral JAK1 Inhibitor Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oral JAK1 Inhibitor Players by Revenue
3.1.1 Global Top Oral JAK1 Inhibitor Players by Revenue (2018-2023)
3.1.2 Global Oral JAK1 Inhibitor Revenue Market Share by Players (2018-2023)
3.2 Global Oral JAK1 Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oral JAK1 Inhibitor Revenue
3.4 Global Oral JAK1 Inhibitor Market Concentration Ratio
3.4.1 Global Oral JAK1 Inhibitor Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oral JAK1 Inhibitor Revenue in 2022
3.5 Oral JAK1 Inhibitor Key Players Head office and Area Served
3.6 Key Players Oral JAK1 Inhibitor Product Solution and Service
3.7 Date of Enter into Oral JAK1 Inhibitor Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oral JAK1 Inhibitor Breakdown Data by Type
4.1 Global Oral JAK1 Inhibitor Historic Market Size by Type (2018-2023)
4.2 Global Oral JAK1 Inhibitor Forecasted Market Size by Type (2024-2029)
5 Oral JAK1 Inhibitor Breakdown Data by Application
5.1 Global Oral JAK1 Inhibitor Historic Market Size by Application (2018-2023)
5.2 Global Oral JAK1 Inhibitor Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Oral JAK1 Inhibitor Market Size (2018-2029)
6.2 North America Oral JAK1 Inhibitor Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Oral JAK1 Inhibitor Market Size by Country (2018-2023)
6.4 North America Oral JAK1 Inhibitor Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oral JAK1 Inhibitor Market Size (2018-2029)
7.2 Europe Oral JAK1 Inhibitor Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Oral JAK1 Inhibitor Market Size by Country (2018-2023)
7.4 Europe Oral JAK1 Inhibitor Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oral JAK1 Inhibitor Market Size (2018-2029)
8.2 Asia-Pacific Oral JAK1 Inhibitor Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Oral JAK1 Inhibitor Market Size by Region (2018-2023)
8.4 Asia-Pacific Oral JAK1 Inhibitor Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oral JAK1 Inhibitor Market Size (2018-2029)
9.2 Latin America Oral JAK1 Inhibitor Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Oral JAK1 Inhibitor Market Size by Country (2018-2023)
9.4 Latin America Oral JAK1 Inhibitor Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oral JAK1 Inhibitor Market Size (2018-2029)
10.2 Middle East & Africa Oral JAK1 Inhibitor Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Oral JAK1 Inhibitor Market Size by Country (2018-2023)
10.4 Middle East & Africa Oral JAK1 Inhibitor Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Detail
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Oral JAK1 Inhibitor Introduction
11.1.4 AbbVie Revenue in Oral JAK1 Inhibitor Business (2018-2023)
11.1.5 AbbVie Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Oral JAK1 Inhibitor Introduction
11.2.4 Pfizer Revenue in Oral JAK1 Inhibitor Business (2018-2023)
11.2.5 Pfizer Recent Development
11.3 Incyte
11.3.1 Incyte Company Detail
11.3.2 Incyte Business Overview
11.3.3 Incyte Oral JAK1 Inhibitor Introduction
11.3.4 Incyte Revenue in Oral JAK1 Inhibitor Business (2018-2023)
11.3.5 Incyte Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Detail
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Oral JAK1 Inhibitor Introduction
11.4.4 Eli Lilly Revenue in Oral JAK1 Inhibitor Business (2018-2023)
11.4.5 Eli Lilly Recent Development
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Detail
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb Oral JAK1 Inhibitor Introduction
11.5.4 Bristol-Myers Squibb Revenue in Oral JAK1 Inhibitor Business (2018-2023)
11.5.5 Bristol-Myers Squibb Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
